Reporting to the General Manager, as a member of the executive leadership team (ELT):• Developed and implemented short and long-term operational and strategic plans aligned with Global strategy• Managed a high-performance team (30 FTEs)• Oversaw all division budgets, forecasts, and profitability analysis• Supported the Compliance committee in risk mitigation exercises and implemented robust procedures (SOP) to reduce corporate risk • Oversaw three product launches in 2021-2022 and prepared three additional launches for 2023

• Built the Medical Affairs department: structure, processes, onboarding, reporting system, and KPIs• Developed and implemented short and long-term operational and strategic plans aligned with Global strategy• Recruited, managed, and mentored a high-performance MSL team (6 FTEs)• Engaged national medical experts with medical and scientific programs• Developed and maintained MSL training programs and material for HCPs• Supported Regulatory Affairs and Market Access for submissions with Health Canada and other government authorities• Supported Marketing for training and strategic/tactical discussions

While leading medical activities for Iclusig, • Conducted a gap analysis for specialty products other than Iclusig • Developed a short and long-term operational and strategic Medical Affairs plan to support all specialty products• Recommended to the ELT the development of a Medical Affairs department

• Developed and implemented medical plans to support MSL Excellence• Collaborated with Global Clinical Operation for local initiatives • Engaged with KOLs to develop scientific programs and supported IIS• Supported Regulatory Affairs and Market Access for submissions • Supported Marketing for training and strategic/tactical discussions

• Developed and implemented strategic/tactical marketing plans• Launched Jakavi in Polycythemia vera (PV)• Collaborated with the Medical Education Department to develop programs aligned with the Brand strategy• Supported sales excellence by providing a clear action plan and tools• Conducted regional consultative meetings and national advisory boards

Delivered Hematology/Oncology portfolio medical affairs plans with medical experts in the assigned territory and supported internal stakeholders in pre- and post-launch phases• Launched five products • Cultivated a peer-to-peer relationship with medical and scientific experts • Involved in strategic discussions by providing actionable insights about products, disease management, and competition to internal stakeholder• Supported the clinical Global and local programs

• Executed medical plans and cultivated a pear-peer relationship with KOLs• Supported HCP information requests about Diagnostic Imaging products• Supported Vasovist and Primovist launches and trained the sales force• Managed safety crisis regarding Gd-CA and nephrogenic systemic fibrosis• Developed a conversion strategy to second-generation Gd-CA

Managed primary market research projects and conducted market analysis to facilitate marketing strategy development

Worked in the Venture Capital Biotechnologies and Life Sciences department to evaluate Biotech business plans (>450), conduct market mapping, and develop financial models to assess return on investment (ROI) and exit scenarios

Worked on several research projects involving photodynamic-based therapies and developed several SOPs and protocols